Obinutuzumab vs. rituximab with chemotherapy in follicular lymphoma

Obinutuzumab vs. rituximab with chemotherapy in follicular lymphoma

User Photo
moasc

3 years
755 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Lauren C. Pinter-Brown MD, FACP, Health Sciences Professor of Medicine and Dermatology, Chao Family Comprehensive Cancer Center, UC-Irvine compares Obinutuzumab vs. rituximab with chemotherapy in follicular lymphoma at the MOASC Spotlight on ASH meeting 2017
Up Next Autoplay